Fig. 1: CONSORT diagram of the Algonquin study.
Belamaf-Pd, belamaf, pomalidomide and dexamethasone. *12 patients from Part 1 and 26 patients from Part 2.
Fig. 1: CONSORT diagram of the Algonquin study. | Nature Medicine
Belamaf-Pd, belamaf, pomalidomide and dexamethasone. *12 patients from Part 1 and 26 patients from Part 2.
